Abstract
Several studies have described the use of orally administered passive antibodies from heterologous species origin to control enteric disease caused by bacteria1–4, viruses5–13, and protozoa14. Both the therapeutic and prophylactic properties of passive antibodies have been evaluated. The therapeutic efficacy has been confined to suppressed pathogen shedding with limited effects reported on the acute clinical disease2,12. The reported lack of therapeutic effect on the course of the Escherichia coli and rotavirus diarrhea episodes may be attributed to the self-limiting nature of these diarrheas in healthy patients. Passive antibody is effective in treating Cryptosporidium infection14 and may also be effective in treating chronic diarrhea in immunocompromised patients.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
D. Rivier and J. Sabotka, Exp. Cell Biol. 46: 277 (1978).
C. Mietens, H. Keinhorst, H. Hilpert, H. Gerber, H. Amster, and J. Pahud, Eur. J. Pediatr. 132: 239 (1979).
M. Linggood, P. Porter, and J. Powell, European Patent Application Number 83305051.1, publication number 0102831 (1984).
C. Tacket, G. Losonsky, H. Link, Y. Hoang, P. Guesry, H. Hilpert, and M. Levine, N. Engl. J. Med. 318: 1240 (1988).
D. Snodgrass and P. Wells, Arch. Virol. 52: 201 (1976).
C. Bartz, R. Conklin, C. Tunstall, and J. Steele, J. Infect. Dis. 142: 439 (1980).
J. Bridger and J. Brown, Infect. Immun. 31: 906 (1981).
L. Saif, D. Redman, K. Smith, and K. Theirl, Infect. Immun. 41: 1118 (1983).
J. Sheridan, C. Smith, M. Manak, and L. Aurlian, J. Infec. Dis. 149: 434 (1984).
P. Offit and H. Clark, J. Virol. 54: 58 (1985).
T. Ebina, A. Sato, K. Umezu, N. Ishida, S. Ohyama, A. Ahizumi, K. Aikawa, S. Katagiri, N. Katsushima, A. Imai, S. Kitaoka, H. Suzuki, and T. Konno, Med. Microbiol. Immunol. 174: 177 (1985).
H. Hilpert, H. Brussow, C. Mietens, J. Sidoti, L. Lerner, and H. Werchau, J. Infec. Dis. 156: 158 (1987).
G. Davidson, E. Daniels, H. Nunan, A. Moore, P. Whyte, K. Franklin, P. McCloud, and D. Moore, Lancet Sept. 23: 709 (1989).
S. Tzipori, D. Robertson, and C. Chapman, Brit. Med. J. 293: 1276 (1986).
A. Kapikian, H. Kim, R. Wyatt, W. Cline, J. Arrobio, C. Brandt, W. Rodriquez, D. Sack, R. Chanock, and R. Parrott, N. Engl. J. Med. 294: 965 (1976).
S. Gorbach, B. Kean, D. G. Evans, D. J. Evans, and D. Bessudo, N. Engl. J. Med. 292: 933 (1975).
R. Black, Rev. Infect. Dis. 8: S131 (1986).
D. Taylor and P. Echeverria, Rev. Infect. Dis. 8: S136 (1986).
R. C. Meyer, E. H. Bohl, and E. M. Kahler, Appl. Microbial. 2: 295 (1964).
R. Wyatt, W. James, E. Bohl, K. Theil, L. Saif, A. Kapikian, and R. Chanock, Science 207: 189 (1980).
S. Urasawa, T. Urasawa, and K. Taniguchi, Infect. Immun. 38: 781 (1982).
A. Torres and L. Ji-Huang, J. Virol. 60: 1107 (1986).
H. Malherbe and M. Strictland-Chomley, Arch. Gesamt. Virusforsch. 22: 235 (1967).
M. M. Levine, J. B. Kaper, R. E. Black, and M. L. Clements, Micro. Rev. 47: 510 (1983).
L. J. Saif, K. L. Smith, B. J. Landmeier, E. H. Bohl, K. W. Theil, and D. A. Todhunter, Amer. J. Vet. Res. 45: 49 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cordle, C.T. et al. (1991). Passive Immune Protection from Diarrhea Caused by Rotavirus or E. Coli: An Animal Model to Demonstrate and Quantitate Efficacy. In: Mestecky, J., Blair, C., Ogra, P.L. (eds) Immunology of Milk and the Neonate. Advances in Experimental Medicine and Biology, vol 310. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3838-7_41
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3838-7_41
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6713-0
Online ISBN: 978-1-4615-3838-7
eBook Packages: Springer Book Archive